Redesign Science Inc — Form D
Redesign Science Inc of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2021-07-15. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-07-15
- Form: D
- Accession: 0001790035-21-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Investors: 10
- Date of first sale: 2021-06-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-406408
Issuer
- Name: Redesign Science Inc
- CIK: 0001790035
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 180 VARICK ST, NEW YORK, NY, 10014
- Phone: 6104057966
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Ted Jing | Director | New York, NY |
| Haotian Li | Director | New York, NY |
| David Rooklin | Director | New York, NY |
| Andrew Avorn | Executive Officer | New York, NY |
| David Rooklin | Executive Officer | New York, NY |
| David William Rooklin | Director | NEW YORK, NY |
| David William Rooklin | Executive Officer | NEW YORK, NY |
| Andrew Tucker Avorn | Executive Officer | New York, NY |
| Haotian William Li | Director | NEW YORK, NY |
Other filings by this issuer (1)
More